Works matching AU Santoni, Matteo

Results: 196
    1

    Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)

    Published in:
    Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04043-x
    By:
    • Santoni, Matteo;
    • Roviello, Giandomenico;
    • Grande, Enrique;
    • De Giorgi, Ugo;
    • Fiala, Ondrej;
    • Seront, Emmanuel;
    • Molina-Cerrillo, Javier;
    • Pichler, Renate;
    • Myint, Zin W.;
    • Kucharz, Jakub;
    • Kanesvaran, Ravindran;
    • Büttner, Thomas;
    • Pichler, Martin;
    • Basso, Umberto;
    • Kopecky, Jindrich;
    • Bourlon, Maria T.;
    • Cerbone, Linda;
    • Buchler, Tomas;
    • Pinto, Alvaro;
    • de Liaño, Alfonso Gómez
    Publication type:
    Article
    2
    3
    4
    5

    Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms.

    Published in:
    PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0197035
    By:
    • Berardi, Rossana;
    • Torniai, Mariangela;
    • Partelli, Stefano;
    • Rubini, Corrado;
    • Pagliaretta, Silvia;
    • Savini, Agnese;
    • Polenta, Vanessa;
    • Santoni, Matteo;
    • Giampieri, Riccardo;
    • Onorati, Sofia;
    • Barucca, Federica;
    • Murrone, Alberto;
    • Bianchi, Francesca;
    • Falconi, Massimo
    Publication type:
    Article
    6

    Italian Registry on Rare Urological Tumors (Meet-URO-23): The First Analysis on Collecting Duct Carcinoma of the Kidney.

    Published in:
    Clinical Genitourinary Cancer, 2024, v. 22, n. 5, p. N.PAG, doi. 10.1016/j.clgc.2024.102186
    By:
    • Giudice, Giulia Claire;
    • Maruzzo, Marco;
    • Verzoni, Elena;
    • Procopio, Giuseppe;
    • Bimbatti, Davide;
    • Sepe, Pierangela;
    • Maines, Francesca;
    • Grillone, Francesco;
    • Cavo, Alessia;
    • Santoni, Matteo;
    • Cordua, Nadia;
    • Pecoraro, Giovanna;
    • Prati, Veronica;
    • Napoli, Marilena Di;
    • Ollari, Eli;
    • Caruso, Giuseppe;
    • Simoni, Nicola;
    • Campobasso, Davide;
    • Buti, Sebastiano
    Publication type:
    Article
    7
    8

    Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study.

    Published in:
    Clinical Genitourinary Cancer, 2024, v. 22, n. 2, p. 305, doi. 10.1016/j.clgc.2023.11.013
    By:
    • Marques Monteiro, Fernando Sabino;
    • Fiala, Ondřej;
    • Massari, Francesco;
    • Myint, Zin W.;
    • Kopecky, Jindrich;
    • Kucharz, Jakub;
    • Büttner, Thomas;
    • Grande, Enrique;
    • Bourlon, Maria Teresa;
    • Molina-Cerrillo, Javier;
    • Pichler, Renate;
    • Buchler, Tomas;
    • Seront, Emmanuel;
    • Ansari, Jawaher;
    • Bamias, Aristotelis;
    • Bhuva, Dipen;
    • Vau, Nuno;
    • Porta, Camillo;
    • Fay, Andre Poisl;
    • Santoni, Matteo
    Publication type:
    Article
    9
    10
    11
    12

    Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison.

    Published in:
    Clinical Genitourinary Cancer, 2022, v. 20, n. 3, p. 285, doi. 10.1016/j.clgc.2022.02.003
    By:
    • Santoni, Matteo;
    • Aurilio, Gaetano;
    • Massari, Francesco;
    • Grande, Enrique;
    • Matrana, Marc R.;
    • Rizzo, Mimma;
    • Giorgi, Ugo De;
    • Incorvaia, Lorena;
    • Martignetti, Angelo;
    • Molina-Cerrillo, Javier;
    • Zabalza, Ignacio Ortego;
    • Mollica, Veronica;
    • Rizzo, Alessandro;
    • Battelli, Nicola;
    • Porta, Camillo
    Publication type:
    Article
    13
    14

    Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.

    Published in:
    Targeted Oncology, 2023, v. 18, n. 4, p. 559, doi. 10.1007/s11523-023-00978-2
    By:
    • Santoni, Matteo;
    • Massari, Francesco;
    • Myint, Zin W.;
    • Iacovelli, Roberto;
    • Pichler, Martin;
    • Basso, Umberto;
    • Kopecky, Jindrich;
    • Kucharz, Jakub;
    • Buti, Sebastiano;
    • Rizzo, Mimma;
    • Galli, Luca;
    • Büttner, Thomas;
    • De Giorgi, Ugo;
    • Kanesvaran, Ravindran;
    • Fiala, Ondřej;
    • Grande, Enrique;
    • Zucali, Paolo Andrea;
    • Fornarini, Giuseppe;
    • Bourlon, Maria T.;
    • Scagliarini, Sarah
    Publication type:
    Article
    15

    Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies.

    Published in:
    2022
    By:
    • Santoni, Matteo;
    • Molina-Cerrillo, Javier;
    • Myint, Zin W.;
    • Massari, Francesco;
    • Buchler, Tomas;
    • Buti, Sebastiano;
    • Matrana, Marc R.;
    • De Giorgi, Ugo;
    • Rizzo, Mimma;
    • Zabalza, Ignacio Ortego;
    • Galli, Luca;
    • Zucali, Paolo Andrea;
    • Aurilio, Gaetano;
    • Incorvaia, Lorena;
    • Bassanelli, Maria;
    • Mammone, Giulia;
    • Salfi, Alessia;
    • Isella, Luca;
    • Mollica, Veronica;
    • Grande, Enrique
    Publication type:
    journal article
    16
    17

    Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study.

    Published in:
    Targeted Oncology, 2021, v. 16, n. 5, p. 625, doi. 10.1007/s11523-021-00828-z
    By:
    • Santoni, Matteo;
    • Massari, Francesco;
    • Grande, Enrique;
    • Procopio, Giuseppe;
    • Matrana, Marc R.;
    • Rizzo, Mimma;
    • De Giorgi, Ugo;
    • Basso, Umberto;
    • Milella, Michele;
    • Iacovelli, Roberto;
    • Aurilio, Gaetano;
    • Incorvaia, Lorena;
    • Buti, Sebastiano;
    • Caffo, Orazio;
    • Fornarini, Giuseppe;
    • Carrozza, Francesco;
    • Mollica, Veronica;
    • Rizzo, Alessandro;
    • Farag, Fady;
    • Molina-Cerrillo, Javier
    Publication type:
    Article
    18

    Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis.

    Published in:
    2020
    By:
    • Iacovelli, Roberto;
    • Ciccarese, Chiara;
    • Facchini, Gaetano;
    • Milella, Michele;
    • Urbano, Federica;
    • Basso, Umberto;
    • De Giorgi, Ugo;
    • Sabbatini, Roberto;
    • Santini, Daniele;
    • Berardi, Rossana;
    • Santoni, Matteo;
    • Bracarda, Sergio;
    • Massari, Francesco;
    • Masini, Cristina;
    • De Tursi, Michele;
    • Ricotta, Riccardo;
    • Buti, Sebastiano;
    • Zustovich, Fable;
    • Sepe, Pierangela;
    • Rossetti, Sabrina
    Publication type:
    Correction Notice
    19

    Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis.

    Published in:
    2020
    By:
    • Iacovelli, Roberto;
    • Ciccarese, Chiara;
    • Facchini, Gaetano;
    • Milella, Michele;
    • Urbano, Federica;
    • Basso, Umberto;
    • De Giorgi, Ugo;
    • Sabbatini, Roberto;
    • Santini, Daniele;
    • Berardi, Rossana;
    • Santoni, Matteo;
    • Bracarda, Sergio;
    • Massari, Francesco;
    • Masini, Cristina;
    • De Tursi, Michele;
    • Ricotta, Riccardo;
    • Buti, Sebastiano;
    • Zustovich, Fable;
    • Sepe, Pierangela;
    • Rossetti, Sabrina
    Publication type:
    journal article
    20
    21
    22
    23
    24

    Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy.

    Published in:
    2015
    By:
    • Santoni, Matteo;
    • Buti, Sebastiano;
    • Conti, Alessandro;
    • Porta, Camillo;
    • Procopio, Giuseppe;
    • Sternberg, Cora;
    • Bracarda, Sergio;
    • Basso, Umberto;
    • Giorgi, Ugo;
    • Rizzo, Mimma;
    • Derosa, Lisa;
    • Ortega, Cinzia;
    • Massari, Francesco;
    • Milella, Michele;
    • Bersanelli, Melissa;
    • Cerbone, Linda;
    • Muzzonigro, Giovanni;
    • Burattini, Luciano;
    • Montironi, Rodolfo;
    • Santini, Daniele
    Publication type:
    journal article
    25

    The route to personalized medicine in bladder cancer: where do we stand?

    Published in:
    Targeted Oncology, 2015, v. 10, n. 3, p. 325, doi. 10.1007/s11523-015-0357-x
    By:
    • Massari, Francesco;
    • Ciccarese, Chiara;
    • Santoni, Matteo;
    • Brunelli, Matteo;
    • Conti, Alessandro;
    • Modena, Alessandra;
    • Montironi, Rodolfo;
    • Santini, Daniele;
    • Cheng, Liang;
    • Martignoni, Guido;
    • Cascinu, Stefano;
    • Tortora, Giampaolo
    Publication type:
    Article
    26
    27
    28
    29

    Cross-talk between alpha<sub>1D</sub>-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferation.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-921
    By:
    • Morelli, Maria Beatrice;
    • Amantini, Consuelo;
    • Nabissi, Massimo;
    • Liberati, Sonia;
    • Cardinali, Claudio;
    • Farfariello, Valerio;
    • Tomassoni, Daniele;
    • Quaglia, Wilma;
    • Piergentili, Alessandro;
    • Bonifazi, Alessandro;
    • Del Bello, Fabio;
    • Santoni, Matteo;
    • Mammana, Gabriele;
    • Servi, Lucilla;
    • Filosa, Alessandra;
    • Gismondi, Angela;
    • Santoni, Giorgio
    Publication type:
    Article
    30

    Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03682-w
    By:
    • Massari, Francesco;
    • Santoni, Matteo;
    • Takeshita, Hideki;
    • Okada, Yohei;
    • Tapia, Jose Carlos;
    • Basso, Umberto;
    • Maruzzo, Marco;
    • Scagliarini, Sarah;
    • Büttner, Thomas;
    • Fornarini, Giuseppe;
    • Myint, Zin W.;
    • Galli, Luca;
    • Souza, Vinicius Carrera;
    • Pichler, Renate;
    • De Giorgi, Ugo;
    • Gandur, Nathalia;
    • Lam, Elaine T.;
    • Gilbert, Danielle;
    • Popovic, Lazar;
    • Grande, Enrique
    Publication type:
    Article
    31

    Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 2961, doi. 10.1007/s00262-023-03469-5
    By:
    • Santoni, Matteo;
    • Myint, Zin W.;
    • Büttner, Thomas;
    • Takeshita, Hideki;
    • Okada, Yohei;
    • Lam, Elaine T.;
    • Gilbert, Danielle;
    • Küronya, Zsófia;
    • Tural, Deniz;
    • Pichler, Renate;
    • Grande, Enrique;
    • Crabb, Simon J.;
    • Kemp, Robert;
    • Massari, Francesco;
    • Scagliarini, Sarah;
    • Iacovelli, Roberto;
    • Vau, Nuno;
    • Basso, Umberto;
    • Maruzzo, Marco;
    • Molina-Cerrillo, Javier
    Publication type:
    Article
    32
    33

    Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1365, doi. 10.1007/s00262-022-03349-4
    By:
    • Santoni, Matteo;
    • Rizzo, Alessandro;
    • Kucharz, Jakub;
    • Mollica, Veronica;
    • Rosellini, Matteo;
    • Marchetti, Andrea;
    • Tassinari, Elisa;
    • Monteiro, Fernando Sabino Marques;
    • Soares, Andrey;
    • Molina-Cerrillo, Javier;
    • Grande, Enrique;
    • Battelli, Nicola;
    • Massari, Francesco
    Publication type:
    Article
    34
    35
    36
    37

    Is There a Role for Immunotherapy in Prostate Cancer?

    Published in:
    Cells (2073-4409), 2020, v. 9, n. 9, p. 2051, doi. 10.3390/cells9092051
    By:
    • Rizzo, Alessandro;
    • Mollica, Veronica;
    • Cimadamore, Alessia;
    • Santoni, Matteo;
    • Scarpelli, Marina;
    • Giunchi, Francesca;
    • Cheng, Liang;
    • Lopez-Beltran, Antonio;
    • Fiorentino, Michelangelo;
    • Montironi, Rodolfo;
    • Massari, Francesco
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44

    Role of maspin in cancer.

    Published in:
    Clinical & Translational Medicine, 2013, v. 2, n. 1, p. 1, doi. 10.1186/2001-1326-2-8
    By:
    • Berardi, Rossana;
    • Morgese, Francesca;
    • Onofri, Azzurra;
    • Mazzanti, Paola;
    • Pistelli, Mirco;
    • Ballatore, Zelmira;
    • Savini, Agnese;
    • De Lisa, Mariagrazia;
    • Caramanti, Miriam;
    • Rinaldi, Silvia;
    • Pagliaretta, Silvia;
    • Santoni, Matteo;
    • Pierantoni, Chiara;
    • Cascinu, Stefano
    Publication type:
    Article
    45

    The Identification of Immunological Biomarkers in Kidney Cancers.

    Published in:
    Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00456
    By:
    • Lopez-Beltran, Antonio;
    • Henriques, Vanessa;
    • Cimadamore, Alessia;
    • Santoni, Matteo;
    • Cheng, Liang;
    • Gevaert, Thomas;
    • Blanca, Ana;
    • Massari, Francesco;
    • Scarpelli, Marina;
    • Montironi, Rodolfo
    Publication type:
    Article
    46
    47
    48
    49
    50